Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,500 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,523 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,500 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,523 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Other acquisition or disposition -- --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jun 13, 2017
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,170 $6.48
Jun 13, 2017
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --
Jun 03, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Jun 03, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 9,395 $5.96
Apr 17, 2017
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 8,205 $6.32
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 4,713 $6.69
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 116,959 --
Mar 28, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,163 --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Mar 28, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 6,860 $6.69

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.